Top 20 Genomics Companies in the World
20. Anavex Life Sciences Corp. (NASDAQ:AVXL)
Latest Market Capitalization: $505 million
Anavex Life Sciences Corp. (NASDAQ:AVXL) is a biotechnology firm that uses genomic data from research to select biomarkers that can be used to treat diseases such as Alzheimer's. The firm's shares are rated Buy on average, and analysts are quite optimistic about the stock as they have priced in a $41 upside over the current share price.
As of Q2 2023 end, nine out of the 910 hedge funds part of Insider Monkey's database had bought Anavex Life Sciences Corp. (NASDAQ:AVXL)'s shares. Out of these, the firm's biggest shareholder is Israel Englander's Millennium Management since it owns 248,297 shares that are worth $2 million.
Along with Genscript Biotech Corporation (OTCMKTS:GNNSF), Ionis Pharmaceuticals, Inc. (NASDAQ:IONS), and Illumina, Inc. (NASDAQ:ILMN), Anavex Life Sciences Corp. (NASDAQ:AVXL) is a top genomics company.